Press release
Acromegaly Market Expansion Continues, with Forecast Valuation of $4.92 Billion by 2029
Acromegaly
Acromegaly Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of acromegaly has witnessed remarkable acceleration in recent years. The estimated growth is from $2.15 billion in 2024 to $2.57 billion in 2025, representing a compound annual growth rate (CAGR) of 19.6%. Factors such as the heightened prevalence of acromegaly therapeutics, rising awareness regarding acromegaly, government interventions, and an increasing demand for viable treatments have all contributed to the growth experienced in the historical period.
Acromegaly Market Size Forecast: What's the Projected Valuation by 2029?
We anticipate quick expansion in the acromegaly market size over the upcoming years. By 2029, the market is projected to reach $4.92 billion, with a compound annual growth rate (CAGR) of 17.6%. The forecasted development is largely due to research and development endeavours for acromegaly treatments, an uptick in screening initiatives, higher healthcare expenditure, and the escalating requirement for minimally invasive treatment alternatives. Promising trends for the forecast period involve ground-breaking acromegaly treatments, the creation of targeted therapy for acromegaly, a powerful line-up of upcoming drugs, improvements in treatment choices, and cutting-edge personalized medicine.
View the full report here:
https://www.thebusinessresearchcompany.com/report/acromegaly-global-market-report
What Are the Drivers Transforming the Acromegaly Market?
An expected surge in hormonal diseases such as diabetes is anticipated to push the acromegaly market's progress forward. Endocrine disorders, alternatively referred to as hormonal diseases, are health issues due to a breakdown in the endocrine system. Amidst these disorders, diabetes prominently stands out. Some hormones' overproduction can trigger acromegaly and other endocrine diseases, examples include growth hormone or cortisol. Furthermore, the overproduction of the growth hormone could potentially impact insulin synthesis, thereby leading approximately 50% of those with acromegaly to develop insulin resistance or type 2 diabetes mellitus. For instance, the Office for Health Improvement and Disparities, a government agency in the UK, reported in March 2024 that between March 2022 and March 2023, patients with type 1 diabetes witnessed a 22% increase in the reception of all eight recommended care processes. Similarly, for patients with type 2 diabetes, a surge of 21% was noticed. Meanwhile, the percentage meeting the target HbA1c levels increased to 37.9%, according to the National Diabetes Audit (NDA), which represents a historical peak. This surge in hormonal diseases' incidences thus acts as a primary propellant for the acromegaly market's growth. Acromegaly Market Driver: Impact of Genetic Abnormalities on the Growth of the Acromegaly Market
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12913&type=smp
What Long-Term Trends Will Define the Future of the Acromegaly Market?
Leading businesses in the acromegaly market are pioneering the creation of innovative products and solutions, including generic lanreotide, to expand treatment opportunities and boost patient recovery rates. Generic lanreotide is a formulation not linked to a specific brand that is used in the treatment of acromegaly and certain neuroendocrine tumors. It serves as a somatostatin analogue, decreasing secretion of growth hormone and increasing patient access to effective treatment alternatives. For example, Teva Pharmaceutical Industries Ltd., a pharmaceutical company based in Israel specializing in generic drugs, released the first and only generic version of Sandostatin LAR Depot in the United States in October 2024. Octreotide acetate, the injectable suspension this refers to, is used to treat acromegaly and severe diarrhea stemming from carcinoid syndrome. This launch improves the availability of essential therapy for patients needing these treatments.
Which Segments in the Acromegaly Market Offer the Most Profit Potential?
The acromegaly market covered in this report is segmented -
1) By Type: Ectopic Acromegaly, Acromegaly Due To Growth Hormone
2) By Diagnosis: GH And IGF-I Measurement, Growth Hormone Suppression Test, Imaging, Other Diagnosis
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By Treatment: Medication, Somatostatin analogues, Dopamine Agonists, Growth Hormone Antagonist, Surgery, Radiation, Other Treatments
5) By End Users: Hospitals, Specialty Clinics, Homecare, Other End Users
Subsegments:
1) By Ectopic Acromegaly: Tumor-Induced Ectopic Acromegaly, Non-Tumor-Induced Ectopic Acromegaly
2) By Acromegaly Due To Growth Hormone: Primary Growth Hormone Excess, Secondary Growth Hormone Excess
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12913&type=smp
Which Firms Dominate the Acromegaly Market by Market Share and Revenue in 2025?
Major companies operating in the acromegaly market are Pfizer Inc., Johnson & Johnson Private Limited, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH., Amgen Inc., Allergan Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Ipsen Pharma S.A., Hikma Pharmaceuticals PLC, Lupin Ltd., Recordati S.p.A., Ionis Pharmaceuticals Inc., Amryt Pharma plc, Strongbridge Biopharma PLC, Aquestive Therapeutics Inc., Peptron Inc., Crinetics Pharmaceuticals, Chiasma Inc.
Which Regions Offer the Highest Growth Potential in the Acromegaly Market?
North America was the largest region in the acromegaly market in 2024. The regions covered in acromegaly market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12913
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acromegaly Market Expansion Continues, with Forecast Valuation of $4.92 Billion by 2029 here
News-ID: 4125777 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Acromegaly
Rising Hormonal Disease Prevalence Powers Growth In The Acromegaly Market: Key F …
The Acromegaly Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Acromegaly Market Size During the Forecast Period?
The market size for acromegaly has experienced swift expansion in the latest years. It is projected to rise from $2.15 billion in 2024 to $2.57…
Acromegaly Global Market Report 2025: Surge in Acromegaly Cases Driving Market G …
Rapid growth is expected in the Acromegaly global market, driven by rising awareness, government initiatives, and demand for effective treatments.
What Is The Projected Market Size Of The Global Acromegaly Global Market Report 2025 And Its Growth Rate?
The acromegaly market size is set for considerable growth in the coming years. Key statistics include:
• The market size grew from $2.15 billion in 2024 to an estimated $2.57 billion in 2025.
• This represents…
Exploring Acromegaly Treatment Market Growth
The global acromegaly treatment market is experiencing robust growth, with no signs of slowing down. In 2023, this market reached a significant milestone, boasting a total value of USD 1.61 billion. The future looks even more promising, with a projected compound annual growth rate (CAGR) of 7.65% from 2024 to 2032. By the end of this period, the market is expected to soar to approximately USD 3.12 billion. But what's…
Acromegaly Market - Defeating Acromegaly, Restoring Lives
Newark, New Castle, USA: The "Acromegaly Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Acromegaly Market: https://www.growthplusreports.com/report/acromegaly-market/8421
This latest report researches the industry structure, sales, revenue, price and…
Acromegaly - Drug Pipeline Landscape, 2022
Acromegaly is a rare hormonal condition that results from an excess amount of growth hormone (GH) in the body. The extra amount of GH causes excess growth in the bones and soft tissues of the body. Children with the condition can grow to abnormal heights.
The most common cause of acromegaly is a tumor in your pituitary gland called a pituitary adenoma that causes pituitary gland to release excess growth hormone…
Acromegaly - Drug Pipeline Landscape, 2022
Acromegaly is a rare hormonal condition that results from an excess amount of growth hormone (GH) in the body. The extra amount of GH causes excess growth in the bones and soft tissues of the body. Children with the condition can grow to abnormal heights.
The most common cause of acromegaly is a tumor in your pituitary gland called a pituitary adenoma that causes pituitary gland to release excess growth hormone…
